Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma and Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00556803
What this trial is testing

TACE as an Adjuvant Therapy After Radiofrequency Ablation (RFA) for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Sun Yat-sen University 120
Early research (Phase 1)Active Not RecruitingNCT06005740
What this trial is testing

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

Who this might be right for
Advanced Solid TumorHepatocellular Carcinoma
TORL Biotherapeutics, LLC 70
Testing effectiveness (Phase 2)UnknownNCT06482008
What this trial is testing

HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II Study

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 33
Not applicableUnknownNCT05580224
What this trial is testing

Anatomical Radiofrequency Ablation for Small Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 87
Not applicableUnknownNCT05990959
What this trial is testing

Risk Factors, Prognosis, and Potential Chemoprevention Drugs in Patients With Recurrent Hepatocellular Carcinoma After Curative Surgeries: a Nationwide Retrospective Cohort Study and a Multi-center Prospective Cohort Analysis

Who this might be right for
Hepatocellular Carcinoma RecurrentSurgery
China Medical University Hospital 800
Very early researchStudy completedNCT03982407
What this trial is testing

68 Ga PSMA PET/MRI for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Ajit H. Goenka, MD 5
Not applicableStudy completedNCT05635279
What this trial is testing

Effect of Nutritional Indices on the Prognosis of HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Juan Kang 150
Not applicableUnknownNCT04601961
What this trial is testing

Effects of TIVA Versus Inhalational Anaesthesia on Circulating Tumour Cells in Hepatocellular Carcinoma Patients

Who this might be right for
Circulating Tumor CellHepatocellular Carcinoma
The University of Hong Kong 220
Not applicableLooking for participantsNCT07351669
What this trial is testing

Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular CarcinomaTACE(Transcatheter Arterial Chemoembolization)CT
Zhongda Hospital 121
Testing effectiveness (Phase 2)Looking for participantsNCT07157969
What this trial is testing

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital 300
Early research (Phase 1)Ended earlyNCT00823290
What this trial is testing

Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Erlangen-Nürnberg Medical School 2
Very early researchEnded earlyNCT04601428
What this trial is testing

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center 12
Not applicableLooking for participantsNCT03686709
What this trial is testing

Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment

Who this might be right for
Hepatocellular CarcinomaRadiation Exposure
University of Tennessee 20
Not applicableStudy completedNCT05233098
What this trial is testing

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 6
Large-scale testing (Phase 3)UnknownNCT05056337
What this trial is testing

Toripalimab in Combination With Lenvatinib and TACE for Conversion Therapy in Patients With Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 220
Not applicableActive Not RecruitingNCT06141564
What this trial is testing

Detect and Expunge Concealed Tumors of the Liver

Who this might be right for
Liver Cancer
Johns Hopkins University 360
Not applicableNot Yet RecruitingNCT04053231
What this trial is testing

Hepatocarcinoma Recurrence on the Liver Study - Part2

Who this might be right for
Liver CancerSurgeryRecurrence Tumor+1 more
University of Milano Bicocca 3,000
Testing effectiveness (Phase 2)Looking for participantsNCT07014150
What this trial is testing

Neoadjuvant Therapy of Iparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Resectable
Peking Union Medical College Hospital 33
Early research (Phase 1)Study completedNCT00370513
What this trial is testing

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
GlaxoSmithKline 28
Not applicableUnknownNCT05573282
What this trial is testing

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 50
Next Page